Our Technology Map
HA Drug Applications
Cellular Biopharmaceuticals
Pain-reducing Transdermal Drug Delivery
Advanced Vaccine Adjuvants
AI-powered Immune Analysis
ExoHybrid® Exosomes Plus
Awards are the proof of our innovations.
L: 7th SHIE Silver Award
M: 2022 AII American DAVINCI Gold Medal
Right: MTE 2023 Silver Award
2024 Future Tech Award
21st National Innovation Award
Our History
- Listed on the Go Incubation Board (GISA) as 7671
- Initiated a GMP-compliant dissolvable microneedle manufacturing line
- Launched international business development initiatives
- Guided by the TPEx GISA incubation program
- Established a GTP-compliant biological laboratory
- Joint venture “Derma Aesthetic Lab” for exosome raw-material development
- Silver Award at the Shanghai International Invention & Innovation Expo
- 2024 Future Tech Award
- 21st National Innovation Award
- Designated as a High-Risk Innovative Startup
- Approved for TPEx GISA incubation program recommendation
- Capital increased to NT$33 million
- Established a GTP-compliant laboratory in the CTSP
- Silver Award at the MTE Malaysia International Innovation & Technology Exhibition
- Awarded patent for hyaluronic acid conjugation technology (TW, PCT)
- Awarded patent for transdermal patch technology (TW, CN)
- Awarded patent for multi-point contact lens technology (TW)
- Gold Award at the AII DaVinci International Invention Exhibition
- Ministry of Education program spun-off
- Company established
Our Team
Founder Professor Ping-Shan Lai
- Distinguished Professor, Department of Chemistry, NCHU
- National Innovation Award
- Future Tech Award
- Samyang CRS Award, Controlled Release Society
CEO Chin-Ling Pai
- Over 15 years of experience in the biomedical field
- CEO, Prosche Biomed